Showing results (311-320 of 356) with videos related to
Sort By:
Pageof 36
Ecancermedicalscience|February 23, 2023
Comparison of a U.S. and Zambian Ob/Gyn Residency Training ProgrammeMaya M Hicks, Kenneth Chanda, Mulindi Mwanahamuntu, et al.Immunogenetics|June 25, 1999
A divergent non-classical class I gene conserved in salmonidsB P Shum, R Rajalingam, K E Magor, et al.Journal of Lower Genital Tract Disease|April 1, 2016
Clinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in ZambiaCarla J Chibwesha, Brigitte Frett, Katundu Katundu, et al.Bulletin of the World Health Organization|September 3, 2025
Economic evaluation of thermal ablation compared to cryotherapy and loop diathermy in a screen-and-treat approach to cervical cancer, ZambiaAhmad Fuady, Charlotte Kasempa, Eric Lucas, et al.Journal of Global Oncology|September 23, 2018
Leverage of an Existing Cervical Cancer Prevention Service Platform to Initiate Breast Cancer Control Services in Zambia: Experiences and Early OutcomesLeeya F Pinder, Ronda Henry-Tillman, David Linyama, et al.American Journal of Human Genetics|April 16, 2002
Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulationsM A Hall, P J Norman, B Thiel, et al.Reproductive Sciences (Thousand Oaks, Calif.)|May 23, 2012
Exploring a road map to counter misconceptions about the cervicovaginal microbiome and diseaseJean M Macklaim, Craig R Cohen, Gilbert Donders, et al.Tissue Antigens|April 1, 1994
HLA-B15: a widespread and diverse family of HLA-B allelesW H Hildebrand, J D Domena, S Y Shen, et al.Nature Medicine|June 25, 2024
A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trialPartha Basu, Mulindi Mwanahamuntu, Leeya F Pinder, et al.Gynecologic and Obstetric Investigation|June 16, 2001
Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancerA D Santin, P L Hermonat, A Ravaggi, et al.Pageof 36